Rifampicin (
rifampin) increases the clearance and decreases the bioavailability of
tacrolimus.
Rifabutin is expected to interact similarly, although to a lesser extent.
Tacrolimus levels and effects (e.g. on
renal function) should be monitored as a matter of routine, but it is advisable to increase monitoring if
rifabutin is started or stopped.